These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 18976750)
21. Pituitary suppression in ultrasound-monitored frozen embryo replacement cycles. A randomised study. El-Toukhy T; Taylor A; Khalaf Y; Al-Darazi K; Rowell P; Seed P; Braude P Hum Reprod; 2004 Apr; 19(4):874-9. PubMed ID: 15016780 [TBL] [Abstract][Full Text] [Related]
22. The effects of E2 supplementation from the early proliferative phase to the late secretory phase of the endometrium in hMG-stimulated IVF-ET. Jung H; Roh HK J Assist Reprod Genet; 2000 Jan; 17(1):28-33. PubMed ID: 10754780 [TBL] [Abstract][Full Text] [Related]
23. Comparison between oral and vaginal estrogen usage in inadequate endometrial patients for frozen-thawed blastocysts transfer. Liao X; Li Z; Dong X; Zhang H Int J Clin Exp Pathol; 2014; 7(10):6992-7. PubMed ID: 25400786 [TBL] [Abstract][Full Text] [Related]
24. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women. Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425 [TBL] [Abstract][Full Text] [Related]
25. Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization-embryo transfer. Zhang X; Chen CH; Confino E; Barnes R; Milad M; Kazer RR Fertil Steril; 2005 Feb; 83(2):336-40. PubMed ID: 15705371 [TBL] [Abstract][Full Text] [Related]
26. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients. Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663 [TBL] [Abstract][Full Text] [Related]
27. Correlation of endometrial histology, morphometry, and ultrasound appearance after different stimulation protocols for in vitro fertilization. Rogers PA; Polson D; Murphy CR; Hosie M; Susil B; Leoni M Fertil Steril; 1991 Mar; 55(3):583-7. PubMed ID: 1900484 [TBL] [Abstract][Full Text] [Related]
28. Ultrasonography endometrial patterns in different hormonal treatments to induce ovulation. Beneventi F; Sampaolo P; Polatti F; Filoni GM; Masanti ML; Persiani P; Zara C Radiol Med; 1995 Sep; 90(3):278-83. PubMed ID: 7501834 [TBL] [Abstract][Full Text] [Related]
29. Endometrial inadequacy after treatment with human menopausal gonadotropin/human chorionic gonadotropin. Reshef E; Segars JH; Hill GA; Pridham DD; Yussman MA; Wentz AC Fertil Steril; 1990 Dec; 54(6):1012-6. PubMed ID: 2123159 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of different ovarian stimulation protocols for in vitro fertilization. Pados G; Tarlatzis BC; Bontis J; Lagos S; Papadimas J; Spanos E; Mantalenakis S Gynecol Endocrinol; 1995 Jun; 9(2):103-12. PubMed ID: 7502685 [TBL] [Abstract][Full Text] [Related]
31. Possible factors affecting the development of oocytes in in-vitro maturation. Mikkelsen AL; Smith S; Lindenberg S Hum Reprod; 2000 Dec; 15 Suppl 5():11-7. PubMed ID: 11263532 [TBL] [Abstract][Full Text] [Related]
32. Effect of gonadotrophin priming on in-vitro maturation of oocytes collected from women at risk of OHSS. Son WY; Yoon SH; Lim JH Reprod Biomed Online; 2006 Sep; 13(3):340-8. PubMed ID: 16984762 [TBL] [Abstract][Full Text] [Related]
33. The influence of supraphysiologic estradiol levels on human nidation. Gelety TJ; Buyalos RP J Assist Reprod Genet; 1995 Aug; 12(7):406-12. PubMed ID: 8574066 [TBL] [Abstract][Full Text] [Related]
35. Ultrasonic evaluation of endometrial growth in women with normal cycles during spontaneous and stimulated cycles. Lenz S; Lindenberg S Hum Reprod; 1990 May; 5(4):377-81. PubMed ID: 2113926 [TBL] [Abstract][Full Text] [Related]
36. Sonographic assessment of endometrial pattern and thickness in patients treated with human menopausal gonadotropins. Bohrer MK; Hock DL; Rhoads GG; Kemmann E Fertil Steril; 1996 Aug; 66(2):244-7. PubMed ID: 8690110 [TBL] [Abstract][Full Text] [Related]
37. Leukemia inhibitory factor induces cumulus expansion in immature human and mouse oocytes and improves mouse two-cell rate and delivery rates when it is present during mouse in vitro oocyte maturation. De Matos DG; Miller K; Scott R; Tran CA; Kagan D; Nataraja SG; Clark A; Palmer S Fertil Steril; 2008 Dec; 90(6):2367-75. PubMed ID: 18222433 [TBL] [Abstract][Full Text] [Related]
38. Endometrial morphology and hormonal profiles in in vitro fertilization patients. Barash A; Czernobilsky B; Insler V; Borenstein R; Rosenberg M; Fink A Eur J Obstet Gynecol Reprod Biol; 1992 Apr; 44(2):117-21. PubMed ID: 1587376 [TBL] [Abstract][Full Text] [Related]
39. Controlled ovarian hyperstimulation does not adversely affect endometrial receptivity in in vitro fertilization cycles. Levi AJ; Drews MR; Bergh PA; Miller BT; Scott RT Fertil Steril; 2001 Oct; 76(4):670-4. PubMed ID: 11591397 [TBL] [Abstract][Full Text] [Related]
40. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity. Rossmanith WG; Steffens D; Schramm G Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]